Accessibility Menu
Microbix Biosystems logo

Microbix Biosystems

(OTC) MBXBF

Current Price$0.19
Market Cap$25.69M
Since IPO (2012)-37%
5 Year-61%
1 Year-18%
1 Month-1%

Microbix Biosystems Financials at a Glance

Market Cap

$25.69M

Revenue (TTM)

CA$14.82M

Net Income (TTM)

-CA$5.24M

EPS (TTM)

-$0.03

P/E Ratio

-6.29

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$0.19

Volume

1

Open

$0.19

Previous Close

$0.19

Daily Range

$0.19 - $0.19

52-Week Range

$0.15 - $0.23

Estimated Earnings Date

Aug 13, 2026

MBXBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Microbix Biosystems

Industry

Biotechnology

CEO

Cameron L. Groome

Headquarters

Mississauga, ON L4Z 1P3, CA

MBXBF Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

-33%

Net Income Margin

-39%

Return on Equity

-21%

Return on Capital

-16%

Return on Assets

-16%

Earnings Yield

-15.90%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$25.69M

Shares Outstanding

137.50M

Volume

1

Avg. Volume

6.97K

Financials (TTM)

Gross Profit

CA$9.87M

Operating Income

-CA$1.58M

EBITDA

CA$203.49K

Operating Cash Flow

-CA$80.40K

Capital Expenditure

-CA$798.42K

Free Cash Flow

-CA$878.82K

Cash & ST Invst.

CA$12.13M

Total Debt

CA$8.08M

Microbix Biosystems Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$3.39M

-36.4%

Gross Profit

CA$1.63M

-48.5%

Gross Margin

48.20%

N/A

Market Cap

$25.69M

N/A

Market Cap/Employee

$256.85K

N/A

Employees

100

N/A

Net Income

-CA$1.43M

-7039.8%

EBITDA

-CA$800.91K

-214.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$8.15M

-43.9%

Total Debt

CA$6.81M

+27.3%

Accounts Receivable

CA$3.27M

+30.1%

Inventory

CA$10.10M

+22.1%

Long Term Debt

CA$5.87M

+11.8%

Short Term Debt

CA$943.89K

+864.4%

Return on Assets

-16.18%

N/A

Return on Invested Capital

-15.80%

N/A

Free Cash Flow

-CA$531.77K

-173.7%

Operating Cash Flow

-CA$308.57K

-131.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PVCTProvectus Biopharmaceuticals, Inc.
$0.06-10.29%
DTCFFDefence Therapeutics Inc.
$0.39+5.78%
RVXCFResverlogix Corp.
$0.07+0.00%
CLYYFCelyad Oncology S.A.
$0.25+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$124.57+0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
SMCISuper Micro Computer
$30.46-0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.04-0.02%

Questions About MBXBF

What is the current price of Microbix Biosystems?

Microbix Biosystems is trading at $0.19 per share.

What is the 52-week range for Microbix Biosystems?

Over the past 52 weeks, Microbix Biosystems has traded between $0.15 and $0.23.

How much debt does Microbix Biosystems have?

As of the most recent reporting period, Microbix Biosystems reported total debt of CA$4.87M.

How much cash does Microbix Biosystems have on hand?

Microbix Biosystems reported CA$5.83M in cash and cash equivalents in its most recent financial results.

What is Microbix Biosystems’s dividend yield?

Microbix Biosystems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.